The global automated immunoassay analyzers market registered a significantly high double-digit revenue growth in 2022, and is expected to register a rapidly inclining CAGR over the forecast period. Industry analysis indicates that demand for automated immunoassay analyzers product has been rising substantially and adoption across biotechnology and pharmaceutical industries has been increasing in parallel due to increasing prevalence of chronic diseases such as oncology, cardiovascular, and diabetes and growing need to improve healthcare facilities and encourage modernization in the pharmaceuticals sector. Changing trends and advancements in medical devices are other key factors expected to continue to support market revenue growth over the forecast period.
Immunoassay is a method used to identify the presence of a substance in the human body that such as antigen, antibody, pathogen, hormone, or enzyme. Immunoassay is based on the antigen and antibody specificity principle. Immunoassays have an impact in the area of clinical chemistry. Specific antigens stimulate very specific (unique) immune responses, and the proteins or antibodies from responses can be used to signal the presence of a target compound in a sample. Components of automated immunoassay analyzers typically include an autosampler, reagent dispenser, washer, and detection system. Due to accuracy and fast test time, this analyzer is widely used across various applications. In addition to clinical diagnosis, immunoassays are commonly used in research and improvement and quality control in pharmaceutical & biotechnology, and food & beverage industries. In addition, rising drug and substance abuse and consumption has been resulting in increasing need to conduct drug screening at workplace, military services, and others. the Presence of drugs can be detected using immunoassay tests, and this can be processed rapidly, is inexpensive, and more preferred in initial test for screening. The most commonly conducted drug screens are for cocaine metabolites, marijuana metabolites, amphetamines, phencyclidine, and opiate metabolites.
Request a Sample@ https://www.qyresearchmedical.com/sample/119465
The report provides a detailed view of the market, and includes changing dynamics, detailed market segmentation including trends and scenarios supporting revenue growth as well as restraints and opportunities, regional landscape, analysis of market footprint and reach, market sizing based on historical and current data and revenue, and estimated and projected revenue for the global automated immunoassay analyzers market. It also includes recent trends and developments, competitive landscape, company financials, strategies adopted by key players, and products and services offered.
Automated Immunoassay Analyzers Market: Dynamics
The automated immunoassay analyzers market revenue is expected to increase significantly due to a rapidly changing trends and shift towards automated labs, and this coupled with increasing prevalence of chronic diseases is expected to support market growth to a significant extent going ahead. These devices are popular due to gradual innovations in existing products and expanded clinical applications. The rise in applications of automated immunoassay analyzers is likely also lead to increase in demand and rapid rate of adoption, which are factors expected to drive revenue growth of the global automated immunoassay analyzers market over the forecast period. Recent developments in automation and convergence of technologies have also been contributing to increasing adoption of new and more advanced products in the market. These innovations and subsequent adoption is expected to continue to support revenue growth of the global automated immunoassay analyzers market going forward. Various pharmaceutical and biotechnology firms are increasingly using automated immunoassay analyzers for drug discovery activities and processes. Major players and new entrants in the market compete on the basis of more advanced and efficient immunoassay device features, throughput, and menu expansion to establish a robust position in the market and increase market share by gaining access to hospitals and laboratories to deploy products.
The lack of qualified professionals and labor force can be considered a key factor that could hamper growth of the global automated immunoassay analyzers market to a certain extent over the forecast period. Rising healthcare needs in countries across the globe and unavailability of required healthcare personnel and professionals in underdeveloped and emerging regions are other factors that could negatively impact growth of the market. Stringent regulatory requirements and high costs involved in the transition from traditional to automated tools is also expected to hamper growth of the automated immunoassay analyzers market to a certain extent.
Automated Immunoassay Analyzers Market: Regional Landscape
Based on region, the automated immunoassay analyzers market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for a significantly larger revenue share contribution to the global automated immunoassay analyzers market as compared to other regional markets between 2023 and 2032. Primary factors contributing to revenue growth of the market in North America include regular introduction of new products, well-established medical infrastructure and services, broad patient pool, and presence of major players in countries in the region.
The market in Asia-Pacific region is projected to register the fastest revenue CAGR as compared to other regional markets during the forecast period. Japan is one of the major countries with strong technological advancements and increased use of immunoassay research for a variety of applications. Moreover, to a large extent, China is also leading among other countries in terms of revenue contribution to the Asia Pacific automated immunoassay analyzers market and the trend is expected to continue going ahead.
Major Players Operating in the Automated Immunoassay Analyzers Market:
- Siemens Healthcare
- Roche Diagnostics
- Ortho Clinical Diagnostics
- Luminex Corporation
- Meril Life Sciences
- Abbott Laboratories
- Randox Laboratories
- Becton Dickinson and Company
- Aesku Diagnotics
- Arlington Scientific
- Carolina Liquid Chemistries Corporation
- Perkin Elmer
- Inova DX
Automated Immunoassay Analyzers Market: Segmentation
This report provides results of study and analysis and historical as well as forecasts revenue for the automated immunoassay analyzers market at global, regional, and country levels. The report enables analysis of trends for growth of each segment from 2023 to 2032. For this study has segmented the automated immunoassay analyzers market based on product, application, and region as follows:
- Enzyme-Linked Fluorescent System
- Multiplexed Assay System
- Infectious Diseases
- Drug Monitoring
- Allergy Testing
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119465/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: